Metformin was first used to treat type 2 diabetes in the late 1950s and in 2022 remains the
first-choice drug used daily by approximately 150 million people. An accumulation of …

There has been a rapid escalation of type 2 diabetes (T2D) in developing countries, with
varied prevalence according to rural vs urban habitat and degree of urbanization. Some …

The WHO consolidated guidelines on tuberculosis. Module 2: screening–systematic
screening for tuberculosis disease is an updated and consolidated summary of WHO …

The worldwide increase in the prevalence of diabetes has been most notable in TB-endemic
countries and has led to the re-emerging importance of the association between these two …

The escalating burden of diabetes is increasing the risk of contracting tuberculosis (TB) and
has a pervasive impact on TB treatment outcomes. Therefore, we conducted this systematic …

Background Diabetes mellitus (DM) poses a significant risk for the development of active
tuberculosis (TB) and complicates its treatment. However, there is inconclusive evidence on …

Diabetes mellitus (DM) is a growing epidemic with global proportions. It is estimated that in
2019, 463 million adults aged 20-79 years were living with DM. The latest evidence shows …

Background Diabetes mellitus, particularly type 2 diabetes, is a major public health burden
globally. Diabetes is known to be associated with several comorbidities in high-income …

Introduction Meta-analyses conducted so far on the association between diabetes mellitus
(DM) and the tuberculosis (TB) development risk did not sufficiently take confounders into …

Caused by Mycobacterium tuberculosis, TB is the leading cause of death from an infectious
disease. HIV and diabetes are recognised risk factors for progression of TB disease and …